ReviewSmall (Weinheim an der Bergstrasse, Germany)2026
Application of Hydrogel in the Capture and Detection of Circulating Tumor Cells.
Review in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Circulating tumor cells (CTCs) represent critical biomarkers for liquid biopsy, and their efficient capture and accurate detection hold profound clinical significance for early cancer diagnosis, real-time monitoring of metastasis, and the implementation of personalized therapeutic strategies. As an advanced functional material, hydrogels offer distinctive advantages for CTC capture: their three-dimensional porous architecture facilitates deep cell infiltration and effective physical entrapment; their exceptional biocompatibility preserves CTC viability and functionality; and their tunable physicochemical properties combined with versatile functionalization modalities enable highly specific, affinity-driven targeting. Furthermore, integration of hydrogels with optical or electrochemical transducers allows the development of unified, multifunctional platforms capable of sequential CTC capture, in-situ detection, controlled release, and downstream analysis. This review comprehensively summarizes recent advances in hydrogel-based CTC capture and detection technologies, critically examines key challenges currently impeding clinical translation, and finally outlines future research directions. Synergistic multifunctional integration, stimuli-responsive behavior, standardized and scalable fabrication protocols, and rigorous clinical validation will constitute pivotal pathways toward realizing the practical clinical utility of hydrogel-based CTC capture and detection technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.